In triple-negative breast cancer (TNBC) patients, DEC2 mRNA levels were significantly decreased (P < 0.0001), while DEC1 mRNA levels were significantly increased (P = 0.0196). The gene discussed is BHLHE41; the disease is triple-negative breast carcinoma.